Bifogade filer
Kalender
Tid* | ||
2026-03-05 | 06:00 | Bokslutskommuniké 2025 |
2025-11-26 | 06:00 | Kvartalsrapport 2025-Q3 |
2025-09-17 | 06:00 | Kvartalsrapport 2025-Q2 |
2025-06-25 | N/A | Årsstämma |
2025-06-10 | 06:00 | Kvartalsrapport 2025-Q1 |
2025-03-05 | 06:00 | Bokslutskommuniké 2024 |
2024-12-20 | - | Extra Bolagsstämma 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-09-12 | - | Kvartalsrapport 2024-Q2 |
2024-06-28 | - | Kvartalsrapport 2024-Q1 |
2024-06-27 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2024-06-26 | - | Årsstämma |
2024-03-20 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-09-26 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-06-21 | - | Kvartalsrapport 2023-Q1 |
2023-03-30 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-12-09 | - | Extra Bolagsstämma 2022 |
2022-10-26 | - | Kvartalsrapport 2022-Q3 |
2022-08-15 | - | Kvartalsrapport 2022-Q2 |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-04-19 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2022-04-17 | - | Årsstämma |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-12-29 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-09-08 | - | Kvartalsrapport 2021-Q2 |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-04-14 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2021-04-13 | - | Årsstämma |
2021-02-09 | - | Bokslutskommuniké 2020 |
2020-12-14 | - | Kvartalsrapport 2020-Q3 |
2020-09-30 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2020-06-30 | - | Årsstämma |
2020-06-30 | - | Kvartalsrapport 2020-Q1 |
2019-12-20 | - | Extra Bolagsstämma 2019 |
2019-06-27 | - | Årsstämma |
2019-06-03 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2018-07-02 | - | Split SOFTX 1:50 |
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2024-06-02 06:05:51
SoftOx Solutions AS (SoftOx), a clinical-stage bio pharmaceutical company based
in Norway, announces that it has published its Annual Report for 2023. The Board
of Directors has approved the 2023 annual financial statements prepared in
accordance with the Norwegian Accounting Act and accounting standards and
practices generally accepted in Norway.These documents are also available at the
Company's website, https://soft-ox.com/press-releases-updates/.
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or Ingrid Juven, COO at SoftOx Solutions
AS
Mail: ir@soft-ox.com Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth
Oslo) is a Norwegian medtech/biotech company based in Oslo with the aim of
helping to combat major threats to human health, namely the emergence of
antimicrobial resistance (AMR), biofilm infections in chronic wounds and the
spread of viruses. For more information on SoftOx, visit www.soft-ox.com